- UPSpace Home
- →
- Health Sciences
- →
- Nuclear Medicine
- →
- Research Articles (Nuclear Medicine)
- →
- View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
Please note that UPSpace will be unavailable from Friday, 2 May at 18:00 (South African Time) until Sunday, 4 May at 20:00 due to scheduled system upgrades. We apologise for any inconvenience this may cause and appreciate your understanding.
| dc.contributor.author | Duvenhage, Janie
|
|
| dc.contributor.author | Kahts, Maryke
|
|
| dc.contributor.author | Summers, Beverley
|
|
| dc.contributor.author | Zeevaart, Jan Rijn
|
|
| dc.contributor.author | Ebenhan, Thomas
|
|
| dc.date.accessioned | 2024-11-21T11:56:01Z | |
| dc.date.issued | 2024-11 | |
| dc.description.abstract | Please read abstract in the article. | en_US |
| dc.description.department | Nuclear Medicine | en_US |
| dc.description.embargo | 2025-11-16 | |
| dc.description.librarian | hj2024 | en_US |
| dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
| dc.description.sponsorship | The Nuclear Technologies in Medicine and Bioscience Initiative (NTeMBI). | en_US |
| dc.description.uri | https://www.seminarsinnuclearmedicine.com | en_US |
| dc.identifier.citation | Duvenhage, J., Kahts, M., Summers, B. et al. 2024, 'Highlighting new research trends on Zirconium-89 radiopharmaceuticals beyond antibodies', Seminars in Nuclear Medicine, vol. 54, no. 6, pp. 801-811, doi : 10.1053/j.semnuclmed.2024.10.003. | en_US |
| dc.identifier.issn | 1558-4623 (online) | |
| dc.identifier.issn | 0001-2998 (print) | |
| dc.identifier.other | 10.1053/j.semnuclmed.2024.10.003 | |
| dc.identifier.uri | http://hdl.handle.net/2263/99222 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.rights | © 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Notice : this is the author’s version of a work that was accepted for publication in Seminars in Nuclear Medicine. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Seminars in Nuclear Medicine, vol. 54, no. 6, pp. 801-811, doi : 10.1053/j.semnuclmed.2024.10.003. | en_US |
| dc.subject | Zirconium-89 | en_US |
| dc.subject | Molecular imaging | en_US |
| dc.subject | Zirconium-89 radiopharmaceuticals | en_US |
| dc.subject | Antibodies | en_US |
| dc.subject | SDG-03: Good health and well-being | en_US |
| dc.title | Highlighting new research trends on Zirconium-89 radiopharmaceuticals beyond antibodies | en_US |
| dc.type | Postprint Article | en_US |
